Semi Solid Analytical Development Chemist – Herts

Jason Johal at CK Science is currently recruiting for a Semi Solid Analytical Development Chemist to join a successful pharmaceutical company that that develops a wide variety of medicines and healthcare products from their site in Hertfordshire on a full time, permanent basis.

The Job:

As a Semi Solid Analytical Development Chemist you will be joining an existing team of analysts who form the Analytical Development Group within the R&D department. In return there is an attractive salary, coupled with excellent benefits and career progression opportunities.


 The successful Semi Solid Analytical Development Chemist will have the following qualifications, skills & experiences:

  • Development experience of semi solid product including creams, gels, lotions etc.
  • The ability to perform analytical method validations and cleaning validations
  • A strong theoretical and practical understanding of HPLC and GC  
  • Experience of TLC and Titrimetric analysis
  • Relevant experience in developing and validating analytical methods for semi solid product (preferably in a pharmaceutical environment)
  • Experience of HPLC and GC analysis
  • A degree (or equivalent) in a chemistry based discipline  Jason Johal - Manager at CK Science

How to apply:

Apply online:

For more information and to apply for this Semi Solid Analytical Development Chemist position, please contact Jason Johal via email or call 01438 723 500.  Please quote reference ST24640 in all correspondence.


Are you looking for a new job in the phamaceutical industry? Click here to see our latest pharmaceutical jobs?

Posted in Jobs, NewsTagged in , , , , , , , , , , , , , , , , , ,

Engineering Projects Manager Job in North Scotland

Graeme Pallas at CK Science is currently recruiting for an Engineering Projects Manager to join a blue chip pharmaceutical company based in Northern Scotland.


Engineering Projects Manager Job Description:

As Engineering Projects Manager working with this global pharma company, you will be responsible for managing, coordinating and controlling engineering projects to support the manufacturing process of pharmaceutical products whilst adhering to cGMP.

Other duties of this Engineering Projects Manager position will include:

  • Managing day-to-day plan installation work
  • Prepare commissioning strategies
  • Implement strict project and financial controls on projects and undertake feasibility or scheme designs.

As Engineering Projects Manager, you will not be responsible for any direct reports, however, you will coordinate a team of Project Engineers so good communication and leadership skills are essential.

To be considered for this Engineering role, you will be qualified in an engineering/science subject and/or have demonstrable experience managing engineering projects, ideally, in a GMP regulated environment.

Graeme Pallas - Engineering Recruitment at CK Science

Please contact Graeme for more details.

How to apply:

Please click here to apply online now.

For more information regarding this Engineering Projects Manager position, please contact Graeme Pallas at CK Science on 0191 384 8905 or email Please quote reference DH24362 in all correspondence.

Looking for an Engineering job? Click here to search our current engineering jobs online now.

Posted in Jobs, NewsTagged in , , , , , , , , , , , , , , , , , , ,

North East Pharma Company Set for Expansion

Aesica, a pharmaceutical company based in the North West of England is planning to double its production capability as a result of a recent acquisition of three European manufacturing sites. The acquisition of the leading biopharma company UCB by the Newcastle-based Aesica, will mark the pharmaceutical company’s first expansion outside the UK. It also demonstrates the firm’s commitment to enhance its service offering to the global pharmaceutical and biotechnology industries. Aesica chief executive Dr Robert Hardy said: “To have secured manufacturing sites in Europe and on such a large scale is testament to our commitment to ensuring Aesica is recognised as a leading player on the world stage. “It was vital that we capitalised on recent successes, such as the acquisition of R5 earlier this year, which has significantly enhanced our development and formulations capability, and ensured that the momentum was carried forward as we looked to acquire assets in Europe, which we believe will be a key market for us in 2011.” Are you looking for a new position in the UK Pharmaceutical Industry? Click here to search our current pharmaceutical jobs online now.

Posted in General, NewsTagged in , , , , , ,

GSK Recruits Masters Students – Drug Discovery Scheme

iStock_000006963239Medium1-150x150As reported by The Recruiter, the global pharmaceutical company GlaxoSmithKline will be recruiting British university students to work on the discovery of the drugs of the future.

The pharma company plans to launch a medicinal chemistry module using students in their third year of their Master of Science study at the University of Nottingham. The project will run over two terms with 12 students and will focus on research, synthesis and testing of PI 3 kinase inhibitors, which are currently under investigation by a number of drug companies. GSK will be researching their potential in the treatment of asthma.

The move comes as large pharmaceutical companies take steps to strengthen partnerships with academia in a bid to boost innovation in research whilst reducing costs.

The scheme will be a great opportunity for students to make a name for themselves as inventors of patents, with the possibility of receiving royalties if their work was translated into a successful drug.

Head of Chemistry at GSK, Dave Allen stated. “This is not a way of saving money, but we are not a charity and we get something back. Our people will mentor, and get a sense of innovation from students.”

Are you looking for a job in Chemistry? Click here to search our current chemistry jobs online now.

Posted in General, NewsTagged in , , , , , , , , , , ,

Synthetic Organic Chemist – UK

We are currently searching for Synthetic Organic Chemists to join a global pharma company based in Hertfordshire, UK.

As a Synthetic Organic Chemist, you will be experienced in Synthetic Organic Chemistry and will have an understanding of drug development. Any experience in Medicinal Chemistry, DMPK, SAR or CNS drug discovery would also be a distinct advantage for this Synthetic Organic Chemist job.

The ideal candidate for this Synthetic Organic Chemist job will also be experienced in the delivery of small molecules and will be able to undertake independent planning, troubleshooting and successful execution of efficient synthetic routes to novel compounds.

You will hold a minimum of a degree in Chemistry/Synthetic Organic Chemistry (or equivalent) and will have practical ability in Organic Chemistry and a contemporary knowledge of Synthetic Organic Chemistry. You will have the ability to solve complex synthetic problems and to conduct multistep synthesis. It is essential that you are highly motivated and have the ability to adapt to changing priorities. You will also have an understanding of the importance to deliver the end product/final compound.

Apply now

For more information, or to apply for this Synthetic Organic Chemist job, please contact Jason at CK Science on 01438 723 500 or email Please quote reference ST20084 in all correspondence.

Alternatively, click here to apply for this Synthetic Organic Chemist job online now.

Not quite what you’re looking for? Click here to register your CV with CK Science now.

Posted in General, NewsTagged in , , , , , , , , , , ,

Abbott Labs VP joins French pharma company

lab teamThe Executive Vice President of Abbott Laboratories, Olivier Bohuon, is leaving the company to join the French pharma company, Pierre Fabre Group.

The former president, Richard Gonazlez will step in, leading Abbott’s pharmaceutical division on an interim basis.

Abbott’s pharmaceutical division is responsible for the majority of the companies revenue which is mostly due to their rheumatoid arthritis and Crohn’s Disease injection, Humira. The pharmaceutical division generated $4.1 billion in sales for the first quarter of 2010

Posted in General, NewsTagged in , , , , , , ,